Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Clinical trial NCT01703507 · COMPLETED

Trial details

NCT number: NCT01703507
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma Tumors Metastatic to Brain

Start date: 2012-11-09
Primary completion: 2015-05-20
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.